Rapid nongenomic actions of inhaled corticosteroids on long-acting β 2-agonist transport in the airway

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 6, 2011, Pages 654-659

  Horvath, Gabor ^a,b   Mendes, Eliana S ^a   Schmid, Nathalie ^a   Schmid, Andreas ^a   Conner, Gregory E ^a   Fregien, Nevis L ^a   Salathe, Matthias ^a   Wanner, Adam ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Asthma; Bronchial smooth muscle; Formoterol; Inhaled corticosteroids; Nongenomic; Organic cation transporter

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CICLESONIDE; CORTICOSTERONE; DESCICLESONIDE; FLUTICASONE; FORMOTEROL; HYDROCORTISONE; OCTAMER TRANSCRIPTION FACTOR 4; SALMETEROL; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUSCLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DISPOSITION; DRUG INHIBITION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE FIBER;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; BIOLOGICAL TRANSPORT; BRONCHI; CELLS, CULTURED; DRUG INTERACTIONS; EPITHELIAL CELLS; HUMANS; MYOCYTES, SMOOTH MUSCLE; ORGANIC CATION TRANSPORT PROTEINS;

EID: 80955142750     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.08.002     Document Type: Article

References (32)

1. Sears M.R. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma. Curr Opin Pulm Med 2011, 17(1):23-28.
2. Ducharme F.M., Ni Chroinin M., Greenstone I., Lasserson T.J. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev 2010, 4:CD005533.
3. Miller-Larsson A., Selroos O. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta2-agonists. Curr Pharm Des 2006, 12(25):3261-3279.
4. Suissa S., Dell'Aniello S., Ernst P. Effectiveness of combination therapies in asthma: an observational study. Pulm Pharmacol Ther 2009, 22(3):194-198.
5. Chung K.F., Caramori G., Adcock I.M. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009, 65(9):853-871.
6. Humbert M., Andersson T.L., Buhl R. Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma. Allergy 2008, 63(12):1567-1580.
7. Cooper P.R., Panettieri R.A. Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 2008, 122(4):734-740.
8. Stahn C., Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008, 4(10):525-533.
9. Wendler A., Wehling M. Translational research on rapid steroid actions. Steroids 2009.
10. Mendes E.S., Horvath G., Campos M., Wanner A. Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma. J Allergy Clin Immunol 2008, 121(3):700-704.
11. Horvath G., Mendes E.S., Schmid N., Schmid A., Conner G.E., Salathe M., et al. The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. J Allergy Clin Immunol 2007, 120(5):1103-1109.
12. Papi A., Caramori G., Adcock I.M., Barnes P.J. Rescue treatment in asthma. More than as-needed bronchodilation. Chest 2009, 135(6):1628-1633.
13. Frost A.E. Donor criteria and evaluation. Clin Chest Med 1997, 18(2):231-237.
14. Nlend M.C., Bookman R.J., Conner G.E., Salathe M. Regulator of G-protein signaling protein 2 modulates purinergic calcium and ciliary beat frequency responses in airway epithelia. Am J Respir Cell Mol Biol 2002, 27(4):436-445.
15. Horvath G., Schmid N., Fragoso M.A., Schmid A., Conner G.E., Salathe M., et al. Epithelial organic cation transporters ensure pH dependent drug absorption in the airway. Am J Respir Cell Mol Biol 2007, 36(1):53-60.
16. Schmid A., Bai G., Schmid N., Zaccolo M., Ostrowski L.E., Conner G.E., et al. Real-time analysis of cAMP-mediated regulation of ciliary motility in single primary human airway epithelial cells. J Cell Sci 2006, 119(Pt 20):4176-4186.
17. Kelly H.W. Comparison of inhaled corticosteroids: an update. Ann Pharmacother 2009, 43(3):519-527.
18. Koepsell H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol Sci 2004, 25(7):375-381.
19. Nies A.T., Koepsell H., Damme K., Schwab M. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 2011, 201:105-167.
20. Ehrhardt C., Kneuer C., Bies C., Lehr C.M., Kim K.J., Bakowsky U. Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm Pharmacol Ther 2005, 18(3):165-170.
21. Dobson P.D., Kell D.B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat Rev Drug Discov 2008, 7(3):205-220.
22. Patton J.S., Brain J.D., Davies L.A., Fiegel J., Gumbleton M., Kim K.J., et al. The particle has landed-characterizing the fate of inhaled pharmaceuticals. J Aerosol Med Pulm Drug Deliv 2010, 23(Suppl. 2):S71-S87.
23. Miller-Larsson A., Mattsson H., Hjertberg E., Dahlback M., Tunek A., Brattsand R. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos 1998, 26(7):623-630.
24. Ewing P., Ryrfeldt A., Sjoberg C.O., Andersson P., Edsbacker S., Gerde P. Vasoconstriction after inhalation of budesonide: a study in the isolated and perfused rat lung. Pulm Pharmacol Ther 2010, 23(1):9-14.
25. Selye H. The anesthetic effect of steroid hormones. Proc Soc Exp Biol Med 1941, 46:116-121.
26. Rodrigo G.J. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006, 130(5):1301-1311.
27. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir Med 2007, 101(4):685-695.
28. Revollo J.R., Cidlowski J.A. Mechanisms generating diversity in glucocorticoid receptor signaling. Ann N Y Acad Sci 2009, 1179:167-178.
29. Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996, 97(1 Pt 2):169-176.
30. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31(1):143-178.
31. Horvath G., Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J 2006, 27(1):172-187.
32. Nonaka T., Nave R., McCracken N., Kawashimo A., Katsuura Y. Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549). BMC Pharmacol 2007, 7:12.